TherapeuticsMD Inc reports results for the quarter ended in December - Earnings Summary

TherapeuticsMD

10/03/2022 14:31

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss
of 10 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 8 cents per share.
    * Revenue fell 17.3% to $18.68 million from a year ago; 
analysts
expected $29.39 million. 
    * TherapeuticsMD Inc's reported EPS for the quarter was a
loss
of 10 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * TherapeuticsMD Inc shares had risen by 12.5% this quarter.
    * The company reported a quarterly loss of $42.96 million.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 10 at 02:31 p.m.  ​All
figures in US dollars unless otherwise stated